Recombinant human platelet-derived growth factor(Beijing Huaren/Chinese Academy Of Military Medical Sciences)

重组人血小板源生长因子凝胶（北京华芢/中国人民解放军军事医学科学院）

Report date: 2026/03/20 20:03:07

Base Information

Drug NameRecombinant human platelet-derived growth factor(Beijing Huaren/Chinese Academy Of Military Medical Sciences)
Drug Alias Name重组人血小板源生长因子（rhPDGF-BB）凝胶剂
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionPlatelet-derived growth factor receptor agonists
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsBurnsWounds and InjuriesUlcer +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHuaxia Biotechnology (Qingdao) Co LtdChinese Academy Of Military Medical Sciences
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesMilitary Medical Institute Academy of Military Sciences PLA ChinaHuaxia Biotechnology (Qingdao) Co Ltd
Inactive CompaniesN/A
Active IndicationsBurnsUlcerPressure Ulcer +[4] 
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A
Related LinksN/A